Solazyme Successfully Scales Renewable Oil Fermentation to 500,000 Liters at ADM Clinton, Iowa Facility

  Solazyme Successfully Scales Renewable Oil Fermentation to 500,000 Liters at
  ADM Clinton, Iowa Facility

Business Wire

SOUTH SAN FRANCISCO, Calif. -- December 13, 2012

Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company,
announced today the successful completion of multiple initial fermentations at
ADM’s Clinton, Iowa facility. In these runs, Solazyme achieved commercial
scale production metrics, exhibited linear scalability of its process from
laboratory scale, and demonstrated the ability to run at this scale without
contamination. The fermentations were conducted in approximately 500,000-liter
vessels, which are about four times the scale of the vessels in Solazyme’s
Peoria facility. Solazyme is initially targeting annual production of 20,000
metric tons of oil starting in early 2014 at the ADM facility, with targeted
expansion to 100,000 metric tons.

The scale achieved at ADM’s Clinton facility is comparable to the fermentation
equipment currently under construction at the Solazyme Bunge Renewable Oils
facility in Brazil. This 100,000 metric ton annual nameplate capacity facility
in Brazil is on schedule to begin operations in Q4 2013.

“Working with ADM’s world class fermentation team to achieve commercial scale
operations at the ADM facility shortly after announcing the partnership
exhibits our ability to rapidly and successfully scale in large commercial
fermentation facilities,” stated Peter Licari, CTO, Solazyme. “Solazyme is
currently developing commercial facilities in the US, France and Brazil, and
with these runs we have now achieved linear scale-up of over 70,000-fold from
our labs.”

Solazyme is utilizing ADM’s existing Clinton, Iowa, manufacturing facility in
a capital-efficient expansion of its renewable oil production platform in
North America. As part of that arrangement, Solazyme has the ability to fund
certain payments with equity rather than cash. To facilitate the equity
payments, the Company filed a registration statement with the SEC today.

About Solazyme

Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost plant-based sugars into high-value oils.
Headquartered in South San Francisco, Solazyme’s renewable products can
replace or enhance oils derived from the world’s three existing sources –
petroleum, plants and animal fats. Initially, Solazyme is focused on
commercializing its products into three target markets: (1) fuels and
chemicals, (2) nutrition and (3) skin and personal care.

Solazyme®, the Solazyme logo and other trademarks or service names are
trademarks of Solazyme, Inc.

Forward Looking Statements

This press release contains certain forward-looking statements about Solazyme,
including statements that involve risks and uncertainties concerning: its
future ability to run fermentations without meaningful contamination and at
commercial scale metrics; the expected production capacity of the ADM and
Moema facilities; the timing of production at such facilities; the future
expansion of the capacity of the ADM facility; its future ability to scale its
production process in other facilities; and Solazyme's ability to maintain its
relationships with its partners. When used in this press release, the words
"will", "expects", "intends" and other similar expressions and any other
statements that are not historical facts are intended to identify those
assertions as forward-looking statements. Any such statement may be influenced
by a variety of factors, many of which are beyond the control of Solazyme,
that could cause actual outcomes and results to be materially different from
those projected, described, expressed or implied in this press release due to
a number of risks and uncertainties. Potential risks and uncertainties
include, among others: Solazyme's limited operating history; its limited
history in commercializing products; implementation risk in deploying new
technologies; its limited experience in constructing and operating commercial
manufacturing facilities; market acceptance of its products; delays related to
construction or start-up of production facilities; its access to adequate
supply of feedstock on favorable terms; its ability to manage operational
costs at production facilities; its ability to manage operational costs at
production facilities; its ability to enter into and maintain strategic
collaborations; its ability to obtain requisite regulatory approvals; and its
access, on favorable terms, to any required financing. Accordingly, no
assurances can be given that any of the events anticipated by the
forward-looking statements will transpire or occur, or if any of them do so,
what impact they will have on the results of operations or financial condition
of Solazyme.

In addition, please refer to the documents that Solazyme, Inc. files with the
Securities and Exchange Commission, including its Quarterly Reports on Form
10-Q for a discussion of these and other risks. You are cautioned not to place
undue reliance on forward-looking statements, which speak only as of the date
of this press release. Solazyme is not under any duty to update any of the
information in this press release.

Contact:

Solazyme
Genet Garamendi, 650-780-4777
VP Corporate Communications
ggaramendi@solazyme.com
 
Press spacebar to pause and continue. Press esc to stop.